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Background: Infection with Chikungunya alphavirus (CHIKV) can cause severe arthralgia and chronic arthritis in
humans with persistence of the virus in perivascular macrophages of the synovial membrane by mechanisms
largely ill-characterized.
Findings: We herein analysed the innate immune response (cytokine and programmed cell death) of RAW264.7
mouse macrophages following CHIKV infection. We found that the infection was restrained to a small percentage
of cells and was not associated with a robust type I IFN innate immune response (IFN-α4 and ISG56). TNF-α, IL-6
and GM-CSF expression were upregulated while IFN-γ, IL-1α, IL-2, IL-4, IL-5, IL-10 or IL-17 expression could not be
evidenced prior to and after CHIKV exposure. Although CHIKV is known to drive apoptosis in many cell types, we
found no canonical signs of programmed cell death (cleaved caspase-3, -9) in infected RAW264.7 cells.
Conclusion: These data argue for the capacity of CHIKV to infect and drive a specific innate immune response in
RAW264.7 macrophage cell which seems to be polarized to assist viral persistence through the control of apoptosis
and IFN signalling.
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Chikungunya virus (CHIKV) belongs to genus Alphavirus
of the Togaviridae family and was first isolated in Tanza-
nia in 1953 [1,2]. The viral genome is a single strand posi-
tive sense RNA of approximately 12 kb. Together with
other alphaviruses such as Ross river virus (RRV), Semliki
forest virus and Sindbis virus (SINV), they are significant
causes of arthritis in elderly patients [3-6].
The innate immune response can be engaged by sev-
eral virus-associated molecular patterns recognized by a
plethora of pattern recognition receptors (PRRs) such as
toll-like receptors (TLRs), retinoic acid inducible gene-I
(RIG-I) like receptors (RLRs), nucleotide oligomerization
domain like receptors and protein kinase receptor [7,8].
These receptors, upon activation, switch on several* Correspondence: Jean-Jacques.Hoarau@univ-reunion.fr
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reproduction in any medium, provided the orgenes which may regulate a protective response through
the production of interferon (IFN) and IFN-stimulated
genes (ISG).
Apoptosis or programmed cell death is one of the
mechanisms used to limit viral dissemination to other cells
[9]. Caspases are the main executor of apoptosis. Depend-
ing on their role, they are categorized into initiators
(caspase-2,-8,-9-10), effectors or executioners (caspase-3,-
6,-7) and inflammatory caspases (caspase-1,-4, -5) [10,11].
Recent human and non-human primate studies have
shown that CHIKV can infect monocytes/macrophages
and can also persist in perivascular macrophages of the
synovial tissue in chronic conditions [12-15]. Interest-
ingly, only a subset of human monocyte/macrophage
cells (less than 10% of the CD14+ cells) can be infected
in vitro and leading to a rather transient innate immune
response (IL-8, RANTES, IFN-α) which rapidly tails off
at 48h post-infection (PI). Further FACS analyses of the
infected monocyte cultures showed that expression of
activation markers such HLA-DR and adhesion mole-
cules CD54 (ICAM-1), CD106 (VCAM-1), and CD31
(PECAM-1) were not modified after CHIKV infectionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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CHIKV-infected blood monocytes may be associated
with apoptosis by unknown mechanisms [14].
Here we used RAW264.7 mouse cell line to investigate
the capacity of a CHIKV clinical isolate to infect mouse
macrophages. We analysed the IFNα4/ISG56, the apop-
tosis and the cytokine responses prior to and after
CHIKV infection. The relative contribution of these dif-
ferent pathways may help to decipher the plausible role
of persistently CHIKV-infected macrophages in chronic
arthritis as reported in human, monkey and more re-
cently in mice [16].
Materials and methods
CHIKV isolate
CHIKV (clone #4), isolated from a patient’s serum dur-
ing the 2006 epidemic at Reunion island, was collected
as part of the research program supported by a PHRC
(health French Ministry). The research protocol was vali-
dated by the Tours IRB France (Agreement 2006-10)
and collection was consented for by the patient. After
amplification by a single passage on Vero cells, super-
natant was collected when cytopathic conditions were
detected, centrifuged at 2000 rpm and 0.2 μm filtered.
Aliquots were stored at -80°C until used. Serially diluted
(10-1 to 10-12) virus were added to confluent Vero cell
cultured in 96 well plate to establish the TCID50 esti-
mated at 107 /ml.
Cells and culture condition
Cell lines used were: mouse RAW264.7 macrophage
(ECACC, 91062702), mouse CLTT astrocyte, African
green monkey Vero cells (ATCC, CCL-81) and baby
hamster kidney BHK-21 (ATCC, CCL-10). Cells were
maintained in DMEM (PAN Biotech, France) medium,
except BHK-21 in GMEM, containing 10% heat inac-
tivated FCS with penicillin (100U /ml), streptomycin
(0.1 mg/ml), sodium pyruvate (100 mM), L-Glutamine
(200 mM) and fungizone (0.5 μg/ml) at 37°C under 5%
CO2. For BHK-21, medium was supplemented with 10
ml HEPES (PAN Biotech) and 50 ml of tryptose phos-
phate broth (Sigma). Infections were performed by
addition of CHIKV at a multiplicity of infection of 1.
Quantitative RT-PCR (RT-qPCR)
Total RNAs were extracted from culture cells using TRI-
zolW reagent (Invitrogen, France) and quantified using a
picodrop (Labgene scientific, France). Reverse transcription
(RT) was performed in a final volume of 30 μl containing
3 μg of RNA per reaction, 1X RT buffer, 5 μM DTT, 1 Mm
dNTP mix, 7.5 U pDn6 and 60 U RNasin incubated at
65°C for 5 min then cooled in ice for 5 min before addition
of 98.4 u of Reverse transcriptase (MMLV) and again incu-
bated at 37°C for 1 hr followed by 5 min at 95°C. Allproducts were from Promega, France. RNA expression level
between samples, for mouse interferon alpha-4 (IFNα4),
mouse interferon stimulated gene-56 (ISG-56), tumor ne-
crosis factor alpha (TNFα), were performed using SYBR
RT-qPCR with the ABI7500 sequence detection system
(Applied Biosystem, France). Mouse Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as reference
housekeeping gene. Cycling conditions were: 10 min at 95°
C followed by 40 cycles consisting on 15 sec at 95°C, 30 sec
at 60°C and 45 sec at 72°C before a final step to establish
the dissociation curve. Amplicons were verified by 1.2%
agarose gel-electrophoresis. CHIKV absolute quantification
from infected cells and TCS was performed as previously
described using a plasmid containing E1 insert as a stand-
ard, (kindly provided by Prof. X. de Lamballerie, Marseille,
France) [12,17]. Primers used are listed in Table 1.
Amplification of CHIKV positive or negative RNA strands
Total RNAs from CHIKV infected cells (RAW264.7 or
CLTT) or cell culture supernatant were extracted using the
NuclisensW easyMAGW system (bioMerieux SA, France).
2 μl of 20 μM biotinylated primers specific for either posi-
tive strand (CHIKV_Pos) or negative strand (CHIKV_Neg)
of CHIKV E2 gene (CHIKV_E2 primers) were mixed
with 2 μl of total RNA for denaturation at 65°C for 2
minutes in a final volume of 20 μl, then cooled in ice for
5 min. Reverse transcription (RT) was performed in a
final volume of 20 μl using the PrimeScript RT reagent
kit (TAKARA, France), containing 4.5 μl of denaturated
RNA, 4 μl of 5X RT buffer and 1 μl of RT enzyme, in a
thermocycler (Eppendorf, France) at 37°C for 15 min
followed by 5 sec at 85°C. The biotinylated cDNAs were
then purified using the Dynabeads M-270 streptavidin sys-
tem (Invitrogen, France) and finally suspended in 20 μl of
EASY dilution solution (TAKARA, France). 5 μl of puri-
fied cDNA were amplified in a final volume of 20 μl con-
taining 500 nM of primers (CHIKV_ E2), 10 μl of 2X SYBR
Premix Ex Taq II polymerase buffer (TAKARA, France)
with a LightCycler 480/96 (Roche, France). Cycling
conditions were: 30 sec at 95°C followed by 40 cycles
consisting on 5 sec at 95°C, 15 sec at 56°C and 15 sec
at 72°C before a final step to establish the dissociation
curve.
Immunofluorescence staining (IFs)
Adherent cells (RAW264.7 and CLTT cells) were grown
on glass coverslips, washed to remove debris and fixed
by chilled ethanol for 5 min at different time PI. Cells
were incubated at 4°C overnight with primary antibody
in PBS-BSA 1%, washed 3 times in PBS followed by 2
hours incubation at room temperature with secondary
antibody conjugated with Alexa Fluor 488 or 594 and
DAPI (Invitrogen, France) in PBS/BSA. After washing in
PBS, coverslips were mounted in Vectashield (VectorLab,
Table 1 List of primers used
Gene Primer 1 (50→ 30) Primer 2 (50→ 30) Amplicon (bp)
GAPDH GAACGGGAAGCTTGTCATCA TGACCTTGCCCACAGCCTTG 473
IFNα4 AGCCTGTGTGATGCAGGAACC CAGCAAGTTGGTTGAGGAAGAG 171
ISG56 CTCAGAGCAGGTCCAGTTCC TCCATCTCAGCACACTCCAG 300
TNFα ACGGCATGGATCTCAAAGAC CGGACTCCGCAAAGTCTAAG 325
CHIKV_E1 AAGCTYCGCGTCCTTTACCAAG CCAAATTGTCCYGGTCTTCCT 209
Probe_E1 FAM – CCAATGTCYTCMGCCT
GGACACCTTT - TAMRA
CHIKV_E2 ACKCTGACRGTGGGATTYAC ACGTGCTGCAAGGTARCTCT 139
CHIKV_Pos ACGTGCTGCAAGGTARCTCT
CHIKV_Neg ACKCTGACRGTGGGATTYAC
Kumar et al. Virology Journal 2012, 9:313 Page 3 of 8
http://www.virologyj.com/content/9/1/313France), visualized using a Nikon Eclipse 80i microscope
with a Hamamatsu ORCA-ER camera and acquired with
NIS-Element BR v2.30 imaging software (Nikon, France).
Antibodies used were: Mouse monoclonal anti CHIKV E1
clone 6C4A5 (kindly provided by Biomerieux and IMTSSA,
France), FDO (Human serum anti-CHIKV), rabbit anti-
cleaved Caspase 9 (cell signaling, France), polyclonal rabbit
anti-cleaved Caspase-3 (cell signaling), monoclonal rabbit
anti p-IRF3 (cell signaling), polyclonal rabbit anti ISG-15
(cell signaling), rabbit anti-SFV Nsp1 (kindly provided by A.
Merits) and mouse anti-dsRNA J2 (English and scientific
consulting, Hungary). For each marker, photographs were
taken with equal exposure time.
Cytokines titration
Cytokines released by RAW264.7 or CLTT cells in tissue
culture supernatants (TCS) were measured using the
mouse TNFα ELISA Ready-SET-GO kit (eBioscience,
France) and by FACS using the mouse Th1/Th2 10 plex
Flowcytomix kit (eBioscience, France) on a FC500 flow
cytometer (Beckman coulter, France) according to man-
ufacturer’s protocols.
Plaque assay
Supernatant from cell cultures (TCS) infected by CHIKV
were collected at 2, 8, 24 and 48 hrs PI and filtered thru
0.2 μM. 300 μl of diluted supernatant (10-1 to 10-7 dilu-
tion) in serum free GMEM medium was added on con-
fluent BHK-21 cells grown on 6 well plates and
incubated for 1 hour shaking every 10 minutes in an in-
cubator at 37°C under 5% CO2. After infectious media
was aspirated, each well was overlaid with 2 ml of CMC/
GMEM mixture composed of 2 parts of 2% CMC (car-
boxymethylcellulose, Sigma) and 3 parts of complete
GMEM containing 2% FCS, then cultured for 72 hours.
CMC/GMEM mixture was removed and cells were stained
with crystal violet dye solution at room temperature for
30 min. Plates were washed under tap water and the num-
ber of plaques/well were counted to determine the virustitter (pfu/ml) calculated as the number of plaques/well ×
Dilution factor × K (compensation factor to 1 ml).
TUNEL assay
Infected cells were grown on coverslips for 8 and 24 hrs.
To detect cells undergoing apoptosis, the Deadend col-
orimetric TUNEL system (Promega) was used according
to the manufacturer’s protocol. Coverslips were mounted
with permanent mounting medium VectaMount (Vector
laboratories, USA) for analysis.
Statistical analysis
Paired t test statistical analysis was performed using
Sigma plot version 9.0.1 software (Systat, UK). Values
are represented as Mean ± SEM from three independent
experiments.
Results
CHIKV infects and replicates in a subset of RAW264.7
macrophage cells
At 48 hrs PI, we observed that only a subset of RAW264.7
cells was infected in the form of clusters by CHIKV (less
than 5% of the total population) compared to CLTT
(100% infection). We found that infected RAW cells pro-
duced ISG15 but were not stained for phospho IRF3 at
24 h PI although at a level much lower than CLTT astro-
cytes. Simultaneous expression of dsRNA (J2 antibody),
CHIKV structural proteins (E2, E1, Capsid using FDO
human antiserum and mouse anti-E1) and non-structural
protein Nsp1 (antiserum) following CHIKV infection of
RAW 264.7 cells was also observed (Figures 1 and 2). We
used CLTT astrocyte cell line as a positive control of
CHIKV infection as shown previously [18]. The release of
CHIKV particles from infected cells was confirmed by RT-
qPCR and plaque assay. By RT-qPCR, CHIKV RNA was
detected from 8h PI in RAW cells and at a level at least
1000 fold lower when compared to CLTT (Figure 3). In
TCS of infected RAW264.7, a stable level of virus (~ 3 ×
103 pfu/ml) was measured at 8, 24 and 48 hrs PI compared
Figure 1 CHIKV infects and replicates in RAW264.7 mouse macrophages. (A) Immunostainings using FDO (human anti-CHIKV polyclonal
Ab, red fluorescence) and J2 (mouse anti-double stranded RNA, green) or ISG-15 or specific rabbit anti-phospho IRF3 at 24 hrs PI. Nuclei
were counterstained with DAPI (blue). Only a limited number of total RAW264.7 cells were infected (< 5%) in form of clusters, as focused
on here, compared to CLTT (> 95% of infected cells). (B) During the time course of infection, both structural and non-structural proteins
of CHIKV were produced in infected cells as shown by double staining with FDO (green fluorescence) and rabbit anti cross-reacting SFV/
CHIKV Nsp1 antibody (red fluorescence). Nuclei were stained with DAPI (blue fluorescence). Negative controls are shown as insets. *
Cluster of infected cells.
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pfu/ml at 8, 24 and 48 hrs PI). Interestingly, in contrast to
CLTT, the level of CHIKV RNA produced in RAW264.7
cells decreased rapidly between 8 and 24 hrs PI to become
undetectable at 48 h. Positive strands of CHIKV RNA were
detected in both RAW cells and culture supernatants
whereas the negative strand was detected only in RAW
264.7 infected cells (Figure 4).The infection of mouse RAW264.7 macrophage cells by
CHIKV does not lead to apoptosis
The majority of CLTT cells at 24 hrs PI were positive for
both initiator cleaved caspase-9 and executor cleaved
caspase-3 with condensed or fragmented nuclei whereas
among the clusters of infected RAW264.7 cells, these
markers remained negatives and only a few nuclei were
condensed (Figure 2). Moreover, no sign of DNA frag-
mentation was observed by TUNEL assay for RAW264.7
at 24 hrs PI compare to CLTT (Figure 2C).RAW264.7 mounts a rather poor innate immune response
against CHIKV in contrast to CLTT
RT-qPCR analysis showed no significant changes in IFNα4
and ISG-56 mRNA expression levels for RAW264.7 when
compared to CLTT cell line at 24 hrs PI (Figure 5). Since
PRRs are critical sensors to initiate the antiviral innate im-
munity, we also tested TLRs and RIG-I expression in RAW
cells prior to and after CHIKV infection. TLR-3, 7, 8 and 9
were not detected (Ct values > 35) and no significant changes
were found for RIG-I from 8 to 48 h PI (data not shown).Robust TNF-alpha expression in CHIKV-infected RAW264.7
cells
TNFα release was significantly increased at 24 hrs PI (con-
trol: 1025 ± 183 pg/ml to CHIKV-infected RAW: 3421 ±
766 pg/ml, p=0.02) as measured by ELISA and confirmed
by FACS beads array (control: 1021 ± 266 pg/ml; CHIKV:
3931 ± 1207 pg/ml) (Figure 5B). TNFα expression at the






























































Figure 2 RAW264.7 infected cells does not undergo apoptosis. (A& B) Immunofluorescence of RAW264.7 and CLTT at 48 hrs PI
(mouse monoclonal anti-CHIKV E1, green fluorescence) and apoptosis markers (initiator cleaved caspase-9 or executor cleaved caspase-3,
red fluorescence). Nuclei were stained with DAPI (blue fluorescence). (C) No DNA fragmentation (TUNEL assay) was observed in RAW264.7 cells
(Inset, positive control of apoptosis) during the time course of infection.
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8 hrs PI (fold change: 0.6 ± 0.3 over control, not signifi-
cant) (Figure 5B). Low but significantly elevated expres-
sion of IL-6 (46.6 pg/ml) and GM-CSF (395.4 pg/ml) was


























Figure 3 CHIKV replication in RAW (macrophages) and CLTT
(astrocyte control). (A) With time, CHIKV RNA raised in RAW264.7 cells
and supernatants but remained low compared to CLTT as tested by RT-
qPCR for E1 (n=3). The graph was plotted after adjusting the background
level of the residual virus following the washing steps at T0 (2 hrs PI).mock-infected RAW cells. No expression of IFN-γ, IL-1α,
IL-2, IL-4, IL-5, IL-10 or IL-17 was detected by FACS ana-
lysis in RAW TCS prior to and after CHIKV exposure.
Discussion
There is considerable evidence that several RNA/DNA
viruses such as RRV, by Hepatitis C virus (HCV), human im-
munodeficiency virus (HIV), Measles and cytomegalovirus
(CMV) can persist in monocytes macrophages [6,19,20]. In
patients suffering from chronic arthritis post RRV- and
CHIKV- infection, it is generally accepted that inflammation
is associated with productive viral gene expression in
synovial macrophages and despite neutralizing antibodies
and antiviral interferon/cytokine responses [5,6]. Persistence
may be facilitated by down-regulation of pro-inflammatory
cytokine responses by virus-antibody complexes binding to
Fc receptors, the induction of immunoregulatory
interleukin-10 and phagocytosis of apoptotic virus-infected
cells in a non-phlogistic manner [6,21,22]. Another strategy
developed by viruses to persist in infected cells is to render
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Figure 4 CHIKV positive and negative RNA strands expression. Positive (+) and negative (-) E2 RNAs were detected at very high levels in
CLTT cells ( both in cells and supernatants) whereas RAW264.7 expressed the positive strand at level 1000 fold lower than CLTT (both in cells and
supernatants) while the negative strand was detected at a low level and only in cell extract. The quantity of RNA strands (arbitrary unit) was
estimated with the ΔCt method as 2-Δct with ΔCt = Ct (at 8 h or 48 h PI) – Ct (at T0). Ndt (Not detected).
A IFN-α4





















































































   (P = 0.03) (P = 0.009)
(P = 0.03) (P = 0.02)
Figure 5 Polarized innate immune response in CHIKV-infected RAW264.7. (A) During the time course of infection, RAW264.7 shows no
significant change in IFNα4 mRNA expression by RT-qPCR compared to CLTT. However, a significant increase of ISG-56 at 24 hrs PI was measured
for CLTT (fold increase = 121.5 ± 11.5) compare to RAW264.7 (0.7 ± 0.1). (B) A significant increase of TNFα for RAW264.7 at 24 hr PI (fold
change = 17.9 ± 3.2) was observed by RT-qPCR and validated by ELISA (fold change = 3.3 ± 0.3). Fold change over non-infected control is
expressed as mean ± SEM of three independent experiments.
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[23,24]. Our understanding of the possible contribution of
these different mechanisms to control CHIKV-persistence
and to polarize the innate immune macrophage responses is
still in its infancy.
It has already been shown that CHIKV can infect
human monocytes/macrophages [12-15] but little is
known about the cell response to the infection. Our
study shows for the first time that mouse macrophage
cell line RAW264.7 can be infected by CHIKV. Interest-
ingly, this occurs only for a subset of cells and spreading
to surrounding cells to form clusters of infected cells.
In opposite to previous studies which only shown the
capacity of CHIKV to infect macrophages (both cell lines
and primary cultures) [15,21], we demonstrate here that
RAW264.7 macrophage cells were able to produce also
competent CHIKV particles (PFU) during the early
phase of infection and this was confirmed by the cap-
acity of the virus to replicate its genome evidenced by
the detection of the negative strand RNA. Remarkably,
the level of infectious particles produced by RAW cells
was much lower when compared to that of CLTT astro-
cyte cell line.
Type I IFN dependent innate immune response plays an
effective role against alphavirus infection [25]. Type I IFN
also induces expression of ISGs with antiviral, anti-
proliferative and immunomodulatory functions. No sig-
nificant changes of IFNα4 and ISG56 expression in RAW
macrophage cells were observed in contrast to robust type
I IFN and ISG56 levels in CLTT astrocyte cell line at the
same MOI and time PI. Although a low level of ISG15
was evidenced in RAW264.7 infected cells, which could
also be induced by IFN-independent pathways [26], only
weak levels of phospho-IRF3 translocating to the nucleus
was detected. This observation is to be correlated with the
low levels of RIG-I in RAW264.7 macrophage cells (even
after CHIKV infection) while TLR-3, 7, 8 and 9 were not
expressed. Hence, the absence of IFNα and ISG response
in infected-RAW264.7 could be due to the lack of PRRs to
sense virus RNA and proteins. Many alphaviruses are
known to interfere with the IFNAR/Jak/STAT pathway as
illustrated in CHIKV-infected Vero cells [27] and this
remains to be tested in macrophage cells.
The extrinsic signalling apoptotic pathway involves
death receptors that are members of TNFα receptor
gene family. Interestingly, we have found robust levels of
TNFα mRNA in RAW264.7 cells but not in CLTT astro-
cytes. This finding was confirmed when looking at the
expression of TNFα protein by ELISA and FACS bead
assays of TCS. TNFα signalling, in turn, may control
apoptosis but this hypothesis was not validated in our
RAW264.7 cell model given that cleaved caspase-3 was
not detected in RAW264.7 cells. Cleaved caspase-9
(marker of the intrinsic pathway of apoptosis) was alsonot detected. This finding is in line with the observation
that persistent HIV-1 infection of macrophages is linked
to increased levels of TNFα controlled by NFκB activa-
tion and decreased susceptibility to apoptosis [23,28]. Of
note, a recent study illustrated the capacity of adjuvant
doses of LPS to assist RRV persistence in RAW264.7
cells and this may also involve TLR4/CD14/NFκB signal-
ling to control for apoptosis [29]. Experiments to test
whether these paradigms can explain CHIKV persistence
in macrophages are now highly warranted at least
in vitro.
Understanding the intimate mechanisms of CHIKV-
persistence is a prerequisite to devise new and original
therapies aiming to control for chronic pathologies experi-
enced by patients even 5-6 years post-infection [30].
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